Literature DB >> 26306935

Pharmacologic overview of Withania somnifera, the Indian Ginseng.

Nawab John Dar1,2,3, Abid Hamid2,3, Muzamil Ahmad4,5.   

Abstract

Withania somnifera, also called 'Indian ginseng', is an important medicinal plant of the Indian subcontinent. It is widely used, singly or in combination, with other herbs against many ailments in Indian Systems of Medicine since time immemorial. Withania somnifera contains a spectrum of diverse phytochemicals enabling it to have a broad range of biological implications. In preclinical studies, it has shown anti-microbial, anti-inflammatory, anti-tumor, anti-stress, neuroprotective, cardioprotective, and anti-diabetic properties. Additionally, it has demonstrated the ability to reduce reactive oxygen species, modulate mitochondrial function, regulate apoptosis, and reduce inflammation and enhance endothelial function. In view of these pharmacologic properties, W. somnifera is a potential drug candidate to treat various clinical conditions, particularly related to the nervous system. In this review, we summarize the pharmacologic characteristics and discuss the mechanisms of action and potential therapeutic applications of the plant and its active constituents.

Entities:  

Keywords:  Alzheimer’s disease; Anti-arthritic; Anti-bacterial; Anti-cancer; Anti-diabetic; Anti-inflammatory; Anti-stress; Cardio-protective; Parkinson’s disease; Stroke hypoxia; Withania somnifera

Mesh:

Substances:

Year:  2015        PMID: 26306935     DOI: 10.1007/s00018-015-2012-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  146 in total

1.  Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats.

Authors:  Muzamil Ahmad; Sofiyan Saleem; Abdullah Shafique Ahmad; Mubeen Ahmad Ansari; Seema Yousuf; Md Nasrul Hoda; Fakhrul Islam
Journal:  Hum Exp Toxicol       Date:  2005-03       Impact factor: 2.903

2.  Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation.

Authors:  R Agarwal; S Diwanay; P Patki; B Patwardhan
Journal:  J Ethnopharmacol       Date:  1999-10       Impact factor: 4.360

3.  An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides.

Authors:  Sambamurthy Chandrasekaran; Alti Dayakar; Jalaja Veronica; Shyam Sundar; Radheshyam Maurya
Journal:  Parasitol Int       Date:  2013-02-14       Impact factor: 2.230

4.  Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells.

Authors:  Eun Sun Yang; Min Jung Choi; Jin Hee Kim; Kyeong Sook Choi; Taeg Kyu Kwon
Journal:  Toxicol In Vitro       Date:  2011-09-22       Impact factor: 3.500

5.  Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha.

Authors:  K Kaur; G Rani; Nashi Widodo; A Nagpal; K Taira; S C Kaul; R Wadhwa
Journal:  Food Chem Toxicol       Date:  2004-12       Impact factor: 6.023

6.  The relationship between chondroprotective and antiinflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro.

Authors:  Venil N Sumantran; Rucha Chandwaskar; Asavari Kulkarni Joshi; Sanjay Boddul; Bhushan Patwardhan; Arvind Chopra; Ulhas V Wagh
Journal:  Phytother Res       Date:  2008-10       Impact factor: 5.878

7.  Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation.

Authors:  J A SoRelle; T Itoh; H Peng; M A Kanak; K Sugimoto; S Matsumoto; M F Levy; M C Lawrence; B Naziruddin
Journal:  Diabetologia       Date:  2013-01-15       Impact factor: 10.122

8.  Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves.

Authors:  Bolleddula Jayaprakasam; Yanjun Zhang; Navindra P Seeram; Muraleedharan G Nair
Journal:  Life Sci       Date:  2003-11-21       Impact factor: 5.037

9.  Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera.

Authors:  Abhinav Grover; Shashank Prakash Katiyar; Jeyaraman Jeyakanthan; Vikash Kumar Dubey; Durai Sundar
Journal:  BMC Genomics       Date:  2012-12-13       Impact factor: 3.969

10.  Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities.

Authors:  Nadia Alam; Monzur Hossain; Md Abdul Mottalib; Siti Amrah Sulaiman; Siew Hua Gan; Md Ibrahim Khalil
Journal:  BMC Complement Altern Med       Date:  2012-10-07       Impact factor: 3.659

View more
  55 in total

1.  Plants with Anti-Addictive Potential.

Authors:  Eduardo Luis Konrath; Marcelo Dutra Arbo; Bruno Dutra Arbo; Mariana Appel Hort; Elaine Elisabetsky; Mirna Bainy Leal
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Attenuation of Glutamate-Induced Excitotoxicity by Withanolide-A in Neuron-Like Cells: Role for PI3K/Akt/MAPK Signaling Pathway.

Authors:  Nawab John Dar; Naresh Kumar Satti; Prabhu Dutt; Abid Hamid; Muzamil Ahmad
Journal:  Mol Neurobiol       Date:  2017-04-26       Impact factor: 5.590

3.  Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.

Authors:  Elizabeth A Grossman; Carl C Ward; Jessica N Spradlin; Leslie A Bateman; Tucker R Huffman; David K Miyamoto; Jordan I Kleinman; Daniel K Nomura
Journal:  Cell Chem Biol       Date:  2017-09-14       Impact factor: 8.116

4.  Withania somnifera Chemical Constituents' In Vitro Antioxidant Potential and Their Response on Spermatozoa Parameters.

Authors:  Naveed Munir; Zahed Mahmood; Muhammad Shahid; Muhammad Naveed Afzal; Muhammad Jahangir; Syed Muhammad Ali Shah; Imtiaz Mahmood Tahir; Muhammad Riaz; Shoukat Hussain; Muhammad Akram; Fatima Yousaf
Journal:  Dose Response       Date:  2022-03-01       Impact factor: 2.658

5.  Early selective strategies for higher yielding bio-economic Indian ginseng based on genotypic study through metabolic and molecular markers.

Authors:  Surya Chauhan; Trapti Mandliya; Devendra Jain; Arunabh Joshi; Champa Lal Khatik; Abhijeet Singh; Sudhir K Upadhyay; Rohit Jain
Journal:  Saudi J Biol Sci       Date:  2022-01-20       Impact factor: 4.052

Review 6.  Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease.

Authors:  Shanshan Wang; Xianbo Kong; Zhangjing Chen; Guopin Wang; Juan Zhang; Jing Wang
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

7.  Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.

Authors:  Grace Y Sun; Runting Li; Jiankun Cui; Mark Hannink; Zezong Gu; Kevin L Fritsche; Dennis B Lubahn; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2016-05-21       Impact factor: 3.843

8.  Withanone, an Active Constituent from Withania somnifera, Affords Protection Against NMDA-Induced Excitotoxicity in Neuron-Like Cells.

Authors:  Nawab John Dar; Javeed Ahmad Bhat; Naresh Kumar Satti; Parduman Raj Sharma; Abid Hamid; Muzamil Ahmad
Journal:  Mol Neurobiol       Date:  2016-08-19       Impact factor: 5.590

9.  The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.

Authors:  Su-Hyeong Kim; Krishna B Singh; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2021-01-28

10.  Neuroprotective Effects of Withania somnifera on 4-Hydroxynonenal Induced Cell Death in Human Neuroblastoma SH-SY5Y Cells Through ROS Inhibition and Apoptotic Mitochondrial Pathway.

Authors:  Maqsood A Siddiqui; Nida N Farshori; Mai M Al-Oqail; Aditya B Pant; Abdulaziz A Al-Khedhairy
Journal:  Neurochem Res       Date:  2020-10-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.